Detalhe da pesquisa
1.
Fluoropyrimidine type, patient age, tumour sidedness and mutation status as determinants of benefit in patients with metastatic colorectal cancer treated with EGFR monoclonal antibodies: individual patient data pooled analysis of randomised trials from the ARCAD database.
Br J Cancer
; 130(8): 1269-1278, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38402342
2.
ESMO recommendations on the standard methods to detect RET fusions and mutations in daily practice and clinical research.
Ann Oncol
; 32(3): 337-350, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33455880
3.
Recommendation for supportive care in patients receiving concurrent chemotherapy and radiotherapy for lung cancer.
Ann Oncol
; 31(1): 41-49, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31912794
4.
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.
Ann Oncol
; 31(11): 1491-1505, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32853681
5.
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.
Ann Oncol
; 31(10): 1320-1335, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32745693
6.
JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions.
Ann Oncol
; 31(7): 861-872, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32272210
7.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.
Ann Oncol
; 31(4): 451-469, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32081575
8.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.
Ann Oncol
; 31(2): 191-201, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31959336
9.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO.
Ann Oncol
; 31(3): 334-351, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32067677
10.
ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research.
Ann Oncol
; 30(9): 1417-1427, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31268127
11.
ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.
Ann Oncol
; 30(8): 1232-1243, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31056702
12.
Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS.
Ann Oncol
; 30(2): 171-210, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30596843
13.
Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group.
Ann Oncol
; 30(8): 1221-1231, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31050713
14.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic oesophageal cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.
Ann Oncol
; 30(1): 34-43, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30475943
15.
Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.
Ann Oncol
; 30(1): 19-33, 2019 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30475956
16.
A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).
Ann Oncol
; 29(9): 1895-1902, 2018 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30137196
17.
European Society for Medical Oncology (ESMO) position paper on supportive and palliative care.
Ann Oncol
; 29(1): 36-43, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29253069
18.
The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?
Ann Oncol
; 29(5): 1099-1107, 2018 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29438451
19.
Starting the fight in the tumor: expert recommendations for the development of human intratumoral immunotherapy (HIT-IT).
Ann Oncol
; 29(11): 2163-2174, 2018 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30295695
20.
Pan-Asian adapted ESMO consensus guidelines for the management of patients with metastatic colorectal cancer: a JSMO-ESMO initiative endorsed by CSCO, KACO, MOS, SSO and TOS.
Ann Oncol
; 29(1): 44-70, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29155929